PREDICTIVE FACTORS OF RESPONSE TO TOCILIZUMAB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS

被引：0
|
作者：
Reina, D.
Narvaez, J.
Garcia-Diaz, S.
Diaz Torne, C.
Magallares, B.
Hernandez, M. V. [1 ]
Sanmarti, R. [1 ]
Rodriguez de la Serna, A.
Llobet, J.
Corominas, H.
Nolla, J.
机构：
[1] Clin Barcelona, Barcelona, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：449 / 449
页数：1
相关论文
共 50 条
  • [21] DIFFERENTIAL DNA METHYLATION AS A PREDICTOR OF TOCILIZUMAB RESPONSE IN RHEUMATOID ARTHRITIS PATIENTS
    Nair, N.
    Plant, D.
    Isaacs, J.
    Morgan, A.
    Hyrich, K.
    Barton, A.
    Wilsonon, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 220 - 220
  • [22] Doppler ultrasound impacts response to intravenous tocilizumab in rheumatoid arthritis patients
    Morris, Nicolette T.
    Brook, Jenny
    Ben-Artzi, Ami
    Martin, William
    Kermani, Tanaz A.
    Avedikian-Tatosyan, Lynette
    Karpouzas, George
    Nagam, Himakar
    Navarro, Geraldine
    Choi, Soo
    Taylor, Mihaela B.
    Elashoff, David
    Kaeley, Gurjit S.
    Ranganath, Veena K.
    CLINICAL RHEUMATOLOGY, 2021, 40 (12) : 5055 - 5065
  • [23] GOOD RESPONSE ON TOCILIZUMAB FOR PATIENTS WITH RHEUMATOID ARTHRITIS PERSISTS FOR 3 YEARS
    Visman, I. M.
    Kneepkens, E.
    van den Oever, I.
    Turk, S.
    van Beers-Tas, M.
    Nurmohamed, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1048 - 1048
  • [24] Efficacy of Sarilumab in Patients with Rheumatoid Arthritis with and without Previous Response to Tocilizumab
    Verschueren, Patrick
    Emery, Paul
    van Hoogstraten, Hubert
    Fiore, Stefano
    den Broeder, Alfons
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (07) : 852 - 852
  • [25] Body Mass Index and Clinical Response to Tocilizumab in Patients With Rheumatoid Arthritis
    Huang, Hua
    Cen, Han
    Zhou, Li
    Wang, Ting-hui
    Qin, Wen
    Xie, Bin-hua
    Xiao, Dong-Mei
    Wu, Xiu-Di
    Wu, Hua-Xiang
    ARCHIVES OF RHEUMATOLOGY, 2019, 34 (04) : 406 - 413
  • [26] EFFICACY OF SARILUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH AND WITHOUT PREVIOUS RESPONSE TO TOCILIZUMAB
    Verschueren, P.
    Emery, P.
    van Hoogstraten, H.
    Dong, Q.
    Mangan, E. K.
    den Broeder, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 327 - 328
  • [27] Clinical efficacy of tocilizumab in patients with active rheumatoid arthritis in real clinical practice
    Yasuhiko Hirabayashi
    Tomonori Ishii
    Hideo Harigae
    Rheumatology International, 2010, 30 : 1041 - 1048
  • [28] Clinical efficacy of tocilizumab in patients with active rheumatoid arthritis in real clinical practice
    Hirabayashi, Yasuhiko
    Ishii, Tomonori
    Harigae, Hideo
    RHEUMATOLOGY INTERNATIONAL, 2010, 30 (08) : 1041 - 1048
  • [29] PREDICTIVE FACTORS FOR FOOT DISABILITY IN RHEUMATOID ARTHRITIS PATIENTS
    Matei, D.
    Bighea, A.
    Patru, S.
    Traistaru, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 880 - 880
  • [30] PREVALENCE AND PREDICTIVE FACTORS OF OSTEOPOROSIS IN RHEUMATOID ARTHRITIS PATIENTS
    Ben Ayed, H.
    Miladi, S.
    Boussaa, H.
    Makhlouf, Y.
    Souabni, L.
    Ouenniche, K.
    Kassab, S.
    Chekili, S.
    Ben Abdelghani, K.
    Fazaa, A.
    Laatar, A.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S446 - S446
12345